Abstract
Purpose
Hybrid imaging combining single photon emission computed tomography (SPECT) with 131I and X-ray computed tomography (CT) performed at radioablation (RA) for thyroid carcinoma more accurately detects regional lymph node metastases (LNM) than does planar imaging. In this bicentric prospective study we used hybrid imaging in conjunction with histopathological examination to measure LNM frequency in a consecutive group of patients referred for RA due to stage T1 papillary thyroid carcinoma (PTC).
Methods
At the Departments of Nuclear Medicine of the Ludwig Maximilian University of Munich and the Friedrich Alexander University of Erlangen-Nuremberg SPECT/spiral CT is routinely performed in all PTC subjects at the time of RA. Screening of our SPECT/CT databases for PTC patients with T1 histology produced 98 patients from Munich and 53 patients from Erlangen, including 96 of 151 patients with microcarcinoma. In 69 patients of the entire group, cervical lymph node dissection had been performed, whereas nodal staging in the remaining 82 subjects was based on SPECT/CT.
Results
LNM incidence in the whole group was 26% [95% confidence interval (CI): 20–33%] versus 22% (95% CI: 15–31%) in the microcarcinoma subgroup. SPECT/CT was more accurate in 24.5% of our patients than planar imaging with regard to nodal staging.
Conclusion
LNM occurs in one quarter of all patients with T1 PTC, and also in the subset with microcarcinoma. Performing 131I SPECT/CT, either with therapeutic or diagnostic radioactivities, directly after thyroidectomy should provide more accurate staging of T1 PTC, thus facilitating optimal therapeutic management.
References
Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787–803.
Greene FI, Page LI, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging handbook. New York: Springer; 2002.
Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer 2003;98:31–40.
Dietlein M, Moka D, Scheidhauer K, Schmidt M, Theissen P, Voth E, et al. Follow-up of differentiated thyroid cancer: comparison of multiple diagnostic tests. Nucl Med Commun 2000;21(11):991–1000.
Schmidt D, Szikszai A, Linke R, Bautz W, Kuwert T. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med 2009;50:18–23.
Wong KK, Zarzhevsky N, Cahill JM, Frey KA, Avram AM. Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma. Br J Radiol 2009;82:860–76. doi:10.1259/bjr/25645894.
Aide N, Heutte N, Rame JP, Rousseau E, Loiseau C, Henry-Amar M, et al. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer. J Clin Endocrinol Metab 2009;94(6):2075–84.
Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with confidence. 2nd ed. London: British Medical Journal Books; 2000.
Pellegriti G, Scollo C, Lumera G, Regalbutto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004;89:3713–20.
Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Ghuzlan AA, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 2009;94:1162–7.
Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R, Fahey TJ. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 2009;19:473–7.
Acknowledgements
The authors thank Dr. Paul Cumming for his thorough revision of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mustafa, M., Kuwert, T., Weber, K. et al. Regional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT study. Eur J Nucl Med Mol Imaging 37, 1462–1466 (2010). https://doi.org/10.1007/s00259-010-1408-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-010-1408-2